Takeda: CHMP Recommends Approval Of Dengue Vaccine Candidate

TOKYO (dpa-AFX) - Takeda (TAK) announced the CHMP of the European Medicines Agency recommended the approval of the company's dengue vaccine candidate, TAK-003, for the prevention of dengue disease

Related Keywords

Tokyo , Japan , Gary Dubin , European Medicines Agency , More Such Health News , Global Vaccine Business Unit , Takeda , Thmp , Ecommends , Approval , Dengue , Vaccine , Candidate ,